Tritium and deuterium labelling of a kainate receptor antagonist and evaluation as a radioligand
Journal of Labelled Compounds and Radiopharmaceuticals · 2024
DOI: 10.1002/jlcr.4087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2024. Verfasst von Paulina Chałupnik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College in Kraków, Kraków, Poland. Hauptthemen laut MEDLINE: Kainic Acid Receptors, Glutamic Acid. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre Poland, Academy of Sciences of the Czech Republic, Narodowym Centrum Nauki.
Abstract (Originalsprache)
Kainate receptors play a crucial role in mediating synaptic transmission within the central nervous system. However, the lack of selective pharmacological tool compounds for the GluK3 subunit represents a significant challenge in studying these receptors. Recently presented compound 1 stands out as a potent antagonist of GluK3 receptors, exhibiting nanomolar affinity at GluK3 receptors and strongly inhibiting glutamate‐induced currents at homomeric GluK1 and GluK3 receptors in HEK293 cells with K b values of 65 and 39 nM, respectively. This study presents the synthesis of two potent GluK3‐preferring iodine derivatives of compound 1 , serving as precursors for radiolabelling. Furthermore, we demonstrate the optimisation of dehalogenation conditions using hydrogen and deuterium, resulting in [ 2 H]‐ 1 , and demonstrate the efficient synthesis of the radioligand [ 3 H]‐ 1 with a specific activity of 1.48 TBq/mmol (40.1 Ci/mmol). Radioligand binding studies conducted with [ 3 H]‐ 1 as a radiotracer at GluK1, GluK2, and GluK3 receptors expressed in Sf9 and rat P2 membranes demonstrated its potential applicability for selectively studying native GluK3 receptors in the presence of GluK1 and 2‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptor‐blocking ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College in Kraków, Kraków, Poland.
- Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Paulina Chałupnik, Aleš Marek, Piero Temperini, Tommy N Johansen
Förderung
- National Science Centre Poland
- Academy of Sciences of the Czech Republic
- Narodowym Centrum Nauki
- Akademie Věd České Republiky
Zitieren
APA
Chałupnik, P., Marek, A., Hovah, M. E. L., Pickering, D. S., Temperini, P., Donbosco, S., Szymańska, E., & Johansen, T. N. (2024). Tritium and deuterium labelling of a kainate receptor antagonist and evaluation as a radioligand. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4087
Vancouver
Chałupnik P, Marek A, Hovah MEL, Pickering DS, Temperini P, Donbosco S, et al. Tritium and deuterium labelling of a kainate receptor antagonist and evaluation as a radioligand. Journal of Labelled Compounds and Radiopharmaceuticals. 2024. doi:10.1002/jlcr.4087
BibTeX
@article{Chaupnik2024,
author = {Chałupnik, Paulina and Marek, Aleš and Hovah, Marie Emilie Leiticia and Pickering, Darryl S and Temperini, Piero and Donbosco, Stephanie and Szymańska, Ewa and Johansen, Tommy N},
title = {Tritium and deuterium labelling of a kainate receptor antagonist and evaluation as a radioligand},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2024},
doi = {10.1002/jlcr.4087}
}
EUVIMED